Russell Investments Group
ZYME icon

Russell Investments Group’s Zymeworks ZYME Stock Holding History

Russell Investments Group’s Portfolio ZYME Stock Details ZYME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.25M Buy
47,867
+417
+0.9% +$10.6K ﹤0.01% 2346
2026
Q1 		$1.19M Sell
47,450
-10,900
-19% -$258K ﹤0.01% 2129
2025
Q4 		$1.54M Buy
58,350
+902
+2% +$19.7K ﹤0.01% 2011
2025
Q3 		$981K Buy
57,448
+29,136
+103% +$417K ﹤0.01% 2212
2025
Q2 		$355K Buy
28,312
+25,259
+827% +$301K ﹤0.01% 2468
2025
Q1 		$36.4K Sell
3,053
-41,892
-93% -$571K ﹤0.01% 2974
2024
Q4 		$658K Sell
44,945
-4,826
-10% -$67.5K ﹤0.01% 2180
2024
Q3 		$625K Sell
49,771
-730
-1% -$7.95K ﹤0.01% 2206
2024
Q2 		$430K Sell
50,501
-17,887
-26% -$159K ﹤0.01% 2251
2024
Q1 		$719K Buy
68,388
+41,384
+153% +$460K ﹤0.01% 2094
2023
Q4 		$281K Buy
27,004
+21,465
+388% +$171K ﹤0.01% 2361
2023
Q3 		$35.1K Sell
5,539
-15,661
-74% -$116K ﹤0.01% 2798
2023
Q2 		$183K Buy
21,200
+16,300
+333% +$146K ﹤0.01% 2489
2023
Q1 		$44.3K Sell
4,900
-9,244
-65% -$80.6K ﹤0.01% 2729
2022
Q4 		$111K Sell
14,144
-39,611
-74% -$278K ﹤0.01% 2652
2022
Q3 		$330K Sell
53,755
-96,137
-64% -$580K ﹤0.01% 2394
2022
Q2 		$792K Hold
149,892
– – ﹤0.01% 2064
2022
Q1 		$980K Buy
149,892
+35,264
+31% +$314K ﹤0.01% 1978
2021
Q4 		$1.88M Buy
114,628
+9,664
+9% +$201K ﹤0.01% 1837
2021
Q3 		$3.05M Buy
104,964
+20,220
+24% +$672K 0.01% 1563
2021
Q2 		$2.94M Buy
84,744
+82,039
+3,033% +$2.6M ﹤0.01% 1679
2021
Q1 		$85K Sell
2,705
-5,995
-69% -$244K ﹤0.01% 2997
2020
Q4 		$411K Buy
+8,700
New +$404K ﹤0.01% 2506
2020
Q3 		– Sell
-3,552
Closed -$128K – 3266
2020
Q2 		$128K Buy
3,552
+3,000
+543% +$110K ﹤0.01% 2835
2020
Q1 		$19K Buy
+552
New +$22.6K ﹤0.01% 2957

Other funds holding ZYME

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Russell Investments Group's ZYME Position: Q2 2026 in Review

Russell Investments Group increased its Zymeworks (ZYME) stake by 0.88% in Q2 2026, buying an estimated $10.6K and bringing the position to 47,867 shares worth $1.25M. The position accounts for ﹤0.01% of the portfolio, ranked #2346.

Russell Investments Group first reported a position in ZYME in Q1 2020 and has held it in 25 quarters since. The position peaked at $3.05M in Q3 2021. 202 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

  • Russell Investments Group held 47,867 shares of Zymeworks worth $1.25M as of Q2 2026.
  • Russell Investments Group bought 417 Zymeworks shares in Q2 2026, an estimated $10.6K.
  • Zymeworks made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #2346 holding.
  • Russell Investments Group first reported a position in Zymeworks in Q1 2020 and has held it in 25 quarters since.
  • Russell Investments Group's Zymeworks position peaked at $3.05M in Q3 2021.
  • 202 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.